Kurt Tauer is an Oncology physician. OpenAlex indexes 67 publications with 7,250 citations (h-index 24).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7945 Wolf River Blvd
Germantown, TN 381381762
Telephone
901-683-0055Provider last certified this registry record 21 Feb 2024.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202517 payments$19,723openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20251 payment
- Caris MPI, Inc.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
43.4%PD-1 inhibitor17.6%Pembrolizumab100%Part B, office-administered≥39 patientsPlatinum-based Drug9.2%Oxaliplatin96%Carboplatin3%Cisplatin2%Part B, office-administered≥21 patients+ 11 more classes in this area
Blood & clotting
40.7%Iron, parenteral preparations30.5%Ferric carboxymaltose100%Part B, office-administered≥35 patientsErythropoiesis-stimulating Agent10.1%Darbepoetin alfa100%Part B, office-administered≥33 patients+ 2 more classes in this area
Musculoskeletal
5.8%RANK Ligand Inhibitor5.7%Denosumab100%Part B, office-administered≥43 patientsBisphosphonate0.1%Zoledronic acid100%Part B, office-administered≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparison of Metabolic Outcomes of a Belatacept-Based Immunosuppression Regimen in Hispanic versus Non-Hispanic Kidney Transplant Recipients
American Journal of Transplantation
2025 - Sensitized and Unsensitized Kidney Transplant Recipients on a Belatacept-Based Regimen Demonstrate Comparable Allograft Outcomes
American Journal of Transplantation
2025 - NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
Journal of the National Comprehensive Cancer Network
2019
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”